• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗体局部控释的刺激敏感型透明质酸水凝胶

Stimuli-sensitive hyaluronic acid hydrogels for localized and controlled release of antibodies.

作者信息

Firouzabadi Bita Mahdavi, Gigliobianco Maria Rosa, Agas Dimitrios, Sabbieti Maria Giovanna, Alimenti Claudio, Devi Lakshmi Sathi, Casadidio Cristina, Martino Piera Di, Censi Roberta

机构信息

School of Pharmacy, University of Camerino, ChIP Chemistry Interdisciplinary Project Research Centre, Via Madonna delle Carceri, 62032 Camerino, MC, Italy.

Department of Pharmacy, "G. D'Annunzio" Chieti e Pescara University, Via dei Vestini 1, 66100 Chieti, CH, Italy.

出版信息

Eur J Pharm Biopharm. 2025 Jul 8:114804. doi: 10.1016/j.ejpb.2025.114804.

DOI:10.1016/j.ejpb.2025.114804
PMID:40639449
Abstract

Stimuli-sensitive hydrogels are utilized in therapeutic applications for their ability to function as controlled drug delivery systems, particularly as delivery platforms for antibodies in cancer treatment. Their adaptive properties, including biocompatibility, high water retention, and tunable mechanical strength, make them well-suited for local and sustained drug release. In this study, redox-sensitive hydrogels based on thiolated hyaluronic acid (HA-SH) were synthetized as tunable platforms for controlled antibody delivery in cancer therapy. HA-SH hydrogels with different degrees of substitution (DS30, DS50 and DS70) exhibited distinct structural and mechanical properties, with HA-SH DS70 forming a denser network and demonstrating greater stability compared to HA-SH DS30 and DS50. Swelling and degradation studies confirmed redox responsiveness of the gels, with DS30 gel degrading faster than DS50 and DS70 gels in reductive environments. Rheological analysis further showed that higher cross-linking density in DS70 gels enhanced viscosity and mechanical strength compared to DS50 and DS30. Immunoglobulin G (IgG), used as a model drug for immunotherapeutic agents, was loaded into DS30 and DS70 hydrogels. The release followed zero-order kinetics at pH 7.4, highlighting the influence of the polysaccharide intrinsic anionic properties. DS30 hydrogels demonstrated sustained release (85 ± 6 % in 9 days), while DS70 exhibited faster release (71 ± 7 % in 5 days). The IgG release kinetics relied on a dual mechanism involving the combination of gel erosion (depending on DS and structural features), as well as IgG poly-charged nature and its ionic interactions with the hyaluronic acid polymeric network, as highlighted by rheological measurements and differential scanning calorimetry (DSC) analysis. Overall, the study highlights the potential of HA-SH hydrogels as customizable and localized immunotherapeutic delivery systems for controlled and precise cancer treatment.

摘要

刺激敏感水凝胶因其作为可控药物递送系统的功能而被用于治疗应用,特别是作为癌症治疗中抗体的递送平台。它们的适应性特性,包括生物相容性、高保水性和可调机械强度,使其非常适合局部和持续药物释放。在本研究中,基于硫醇化透明质酸(HA-SH)的氧化还原敏感水凝胶被合成作为癌症治疗中可控抗体递送的可调平台。不同取代度(DS30、DS50和DS70)的HA-SH水凝胶表现出不同的结构和机械性能,与HA-SH DS30和DS50相比,HA-SH DS70形成更致密的网络并表现出更大的稳定性。溶胀和降解研究证实了凝胶的氧化还原响应性,在还原环境中,DS30凝胶比DS50和DS70凝胶降解得更快。流变学分析进一步表明,与DS50和DS30相比,DS70凝胶中更高的交联密度增强了粘度和机械强度。免疫球蛋白G(IgG)用作免疫治疗剂的模型药物,被负载到DS30和DS70水凝胶中。在pH 7.4时,释放遵循零级动力学,突出了多糖固有阴离子特性的影响。DS30水凝胶表现出持续释放(9天内为85±6%),而DS70表现出更快的释放(5天内为71±7%)。IgG释放动力学依赖于双重机制,包括凝胶侵蚀(取决于取代度和结构特征)的组合,以及IgG的多电荷性质及其与透明质酸聚合物网络的离子相互作用,流变学测量和差示扫描量热法(DSC)分析突出了这一点。总体而言,该研究突出了HA-SH水凝胶作为可定制和局部免疫治疗递送系统用于可控和精确癌症治疗的潜力。

相似文献

1
Stimuli-sensitive hyaluronic acid hydrogels for localized and controlled release of antibodies.用于抗体局部控释的刺激敏感型透明质酸水凝胶
Eur J Pharm Biopharm. 2025 Jul 8:114804. doi: 10.1016/j.ejpb.2025.114804.
2
Synthesis and swelling studies of modified chitosan smart hydrogels containing alkyl sulfonate anionic pendant groups as microparticles for insulin release.含烷基磺酸根阴离子侧基的改性壳聚糖智能水凝胶作为胰岛素释放微粒的合成与溶胀研究
Sci Rep. 2025 Jul 18;15(1):26166. doi: 10.1038/s41598-025-06494-9.
3
The effect of FeO biosynthesized through the green synthesis of Silybum marianum and HA in the targeted delivery of 5-Fluorouracil to HCT116 cell line.通过水飞蓟素绿色合成法生物合成的FeO及透明质酸在将5-氟尿嘧啶靶向递送至HCT116细胞系中的作用。
Daru. 2025 Jul 31;33(2):27. doi: 10.1007/s40199-025-00568-9.
4
Fabrication, optimization, and validation of penicillin-loaded hydrogels for controlled drug delivery.青霉素载水凝胶的制备、优化和验证及其用于控制药物释放。
J Biomater Sci Polym Ed. 2024 Dec;35(17):2682-2702. doi: 10.1080/09205063.2024.2387953. Epub 2024 Aug 18.
5
Photothermal Modulation of Dynamic Covalent Poly(ethylene glycol)/PEDOT Composite Hydrogels for On-Demand Drug Delivery.用于按需给药的动态共价聚(乙二醇)/聚3,4-乙撑二氧噻吩复合水凝胶的光热调制
ACS Appl Mater Interfaces. 2023 Nov 4. doi: 10.1021/acsami.3c11288.
6
Mucoadhesive in situ forming Gels: Bridging Formulation design and physiological Realities.黏膜黏附原位凝胶:连接制剂设计与生理现实
Int J Pharm. 2025 Aug 20;681:125834. doi: 10.1016/j.ijpharm.2025.125834. Epub 2025 Jun 9.
7
Novel composite hydrogels prepared from carboxymethyl chitosan and polysaccharides extracted from Ononis natrix for controlled release of bioactive molecules.由羧甲基壳聚糖和从药用棘豆中提取的多糖制备的新型复合水凝胶用于生物活性分子的控释。
Int J Biol Macromol. 2025 Jul;318(Pt 1):144880. doi: 10.1016/j.ijbiomac.2025.144880. Epub 2025 Jun 2.
8
Hyaluronic acid and K-carrageenan metal ionic cross-linked polymers: a promising injectable hydrogels for prolonged chemotherapeutic drug delivery.透明质酸与κ-卡拉胶金属离子交联聚合物:一种用于延长化疗药物递送的有前景的可注射水凝胶。
J Biomater Sci Polym Ed. 2025 Jul 3:1-30. doi: 10.1080/09205063.2025.2524059.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Injectable PLGA-based In Situ Forming Subconjunctival Implant for Sustained Ocular Delivery of Ketotifen Fumarate: Formulation, Drug Release, and Biocompatibility Studies.用于富马酸酮替芬眼部持续递送的基于聚乳酸-羟基乙酸共聚物的可注射结膜下原位形成植入物:制剂、药物释放及生物相容性研究
AAPS PharmSciTech. 2025 Jun 2;26(5):153. doi: 10.1208/s12249-025-03142-3.